Drug delivery co., Macroflux, raises $75M
Macroflux Corp., a Mountain View developer of drug delivery technology using patches, has raised $75 million in first-round funding, as it spins out from Johnson & Johnson subsidiary ALZA Corp.
Nomura Phase4 Ventures led the deal, and was joined by New Enterprise Associates and HBM Partners. ALZA has a minority position of less than 20 percent in the spin-off, according to VentureWire (sub required), which first reported the news this morning.
Next Story: Solar start-up SolFocus relies on familiar Indian player: Moser Baer
Previous Story: Roundup: The valley’s lure, Sequoia out of Google, Office 2.0, Lala & more
